Kayce Street
Women's Health · Fort Worth, TXNPI 1407501935
Payments from drug & device makers
Across 88 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$239
- Astellas Pharma US Inc$219
- Exeltis, USA Inc.$168
- Pfizer$154
- AbbVie$154
- Shield Therapeutics Inc$131
- plus $720 from 13 others
What the payments were for
- Food & beverage$1,784100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 10 | $239 |
| Astellas Pharma US Inc | 12 | $219 |
| Exeltis, USA Inc. | 10 | $168 |
| Pfizer | 8 | $154 |
| AbbVie | 8 | $154 |
| Shield Therapeutics Inc | 3 | $131 |
| Sumitomo Pharma America, Inc. | 7 | $129 |
| Organon | 6 | $122 |
| Agile Therapeutics, Inc. | 6 | $97 |
| Millicent US Inc | 4 | $95 |
| Mayne Pharma Commercial LLC | 5 | $81 |
| Baxter Healthcare | 1 | $39 |
| Evofem Biosciences, Inc. | 2 | $37 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Minerva Surgical, Inc | 1 | $17 |
| Molnlycke Health Care US, LLC | 1 | $13 |
How this compares
$1,784 in reported general payments places this provider in the 85th percentile of 609 women's health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $466 |
Paid to pharmacies, not to this prescriber.
Other women's health in Fort Worth
- Shelagh LarsonFort Worth$43K
- Hilary BoothFort Worth$4K
- Janice BrownFort Worth$2K
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Joyce MillerDallas$37K
- Deborah BrownBeaumont$36K
- Joyce MillerOdessa$36K
- Amanda ArmondAustin$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.